Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 390

1.

Bipolar depression: the clinical characteristics and unmet needs of a complex disorder.

McIntyre RS, Calabrese JR.

Curr Med Res Opin. 2019 Aug 5:1-13. doi: 10.1080/03007995.2019.1636017. [Epub ahead of print]

PMID:
31311335
2.

Complex polypharmacy in bipolar disorder: Side effect burden, adherence, and response predictors.

Fung VC, Overhage LN, Sylvia LG, Reilly-Harrington NA, Kamali M, Gao K, Shelton RC, Ketter TA, Bobo WV, Thase ME, Calabrese JR, Tohen M, Deckersbach T, Nierenberg AA.

J Affect Disord. 2019 Jul 2;257:17-22. doi: 10.1016/j.jad.2019.06.050. [Epub ahead of print]

PMID:
31299400
3.

Clinical Evaluation of Cingulum Bundle Connectivity for Neurosurgical Hypothesis Development.

Sweet JA, Beylergil SB, Thyagaraj S, Herring EZ, Drapekin JE, Gao K, Calabrese JR, Miller JP, McIntyre CC.

Neurosurgery. 2019 Jul 2. pii: nyz225. doi: 10.1093/neuros/nyz225. [Epub ahead of print]

PMID:
31264700
4.

Entrainment of Circadian Rhythms to Temperature Reveals Amplitude Deficits in Fibroblasts from Patients with Bipolar Disorder and Possible Links to Calcium Channels.

Nudell V, Wei H, Nievergelt C, Maihofer AX, Shilling P, Alda M, Berrettini WH, Brennand KJ, Calabrese JR, Coryell WH, Covault JM, Frye MA, Gage F, Gershon E, McInnis MG, Nurnberger JI, Oedegaard KJ, Shekhtman T, Zandi PP, Kelsoe JR, McCarthy MJ.

Mol Neuropsychiatry. 2019 Apr;5(2):115-124. doi: 10.1159/000497354. Epub 2019 Apr 4.

PMID:
31192224
5.

Correlation between white blood cell count and mood-stabilising treatment response in two bipolar disorder trials.

Köhler-Forsberg O, Sylvia LG, Bowden CL, Calabrese JR, Thase ME, Shelton RC, McInnis M, Tohen M, Kocsis JH, Ketter TA, Friedman ES, Deckersbach T, Ostacher MJ, Iosifescu DV, McElroy S, Nierenberg AA.

Acta Neuropsychiatr. 2019 Aug;31(4):230-234. doi: 10.1017/neu.2019.19. Epub 2019 Jun 6.

PMID:
31169098
6.

Longitudinally Measured Changes in Somnolence Severity With a Visual Analog Scale in a Randomized Lithium Versus Quetiapine-IR Study in Bipolar Disorder.

Gao K, Su M, Ganocy SJ, Goto T, Yuan C, Fang F, Conroy C, Brownrigg B, Serrano MB, Calabrese JR.

J Clin Psychopharmacol. 2019 May/Jun;39(3):249-253. doi: 10.1097/JCP.0000000000001031.

PMID:
30932950
7.

Double-blind, placebo-controlled trial of pioglitazone for bipolar depression.

Aftab A, Kemp DE, Ganocy SJ, Schinagle M, Conroy C, Brownrigg B, D'Arcangelo N, Goto T, Woods N, Serrano MB, Han H, Calabrese JR, Gao K.

J Affect Disord. 2019 Feb 15;245:957-964. doi: 10.1016/j.jad.2018.11.090. Epub 2018 Nov 13.

PMID:
30699881
8.

The effects of valbenazine on tardive dyskinesia in patients with a primary mood disorder.

McIntyre RS, Calabrese JR, Nierenberg AA, Farahmand K, Yonan C, Siegert S, Burke J.

J Affect Disord. 2019 Mar 1;246:217-223. doi: 10.1016/j.jad.2018.12.023. Epub 2018 Dec 17.

9.

Comorbid anxiety in bipolar CHOICE: Insights from the bipolar inventory of symptoms scale.

Kinrys G, Bowden CL, Nierenberg AA, Hearing CM, Gold AK, Rabideau DJ, Sylvia LG, Gao K, Kamali M, Bobo WV, Tohen M, Deckersbach T, McElroy SL, Ketter TA, Shelton RC, Friedman ES, Calabrese JR, McInnis MG, Kocsis J, Thase ME, Singh V, Reilly-Harrington NA.

J Affect Disord. 2019 Mar 1;246:126-131. doi: 10.1016/j.jad.2018.12.039. Epub 2018 Dec 18.

PMID:
30580198
10.

Chronotype and cellular circadian rhythms predict the clinical response to lithium maintenance treatment in patients with bipolar disorder.

McCarthy MJ, Wei H, Nievergelt CM, Stautland A, Maihofer AX, Welsh DK, Shilling P, Alda M, Alliey-Rodriguez N, Anand A, Andreasson OA, Balaraman Y, Berrettini WH, Bertram H, Brennand KJ, Calabrese JR, Calkin CV, Claasen A, Conroy C, Coryell WH, Craig DW, D'Arcangelo N, Demodena A, Djurovic S, Feeder S, Fisher C, Frazier N, Frye MA, Gage FH, Gao K, Garnham J, Gershon ES, Glazer K, Goes F, Goto T, Harrington G, Jakobsen P, Kamali M, Karberg E, Kelly M, Leckband SG, Lohoff F, McInnis MG, Mondimore F, Morken G, Nurnberger JI, Obral S, Oedegaard KJ, Ortiz A, Ritchey M, Ryan K, Schinagle M, Schoeyen H, Schwebel C, Shaw M, Shekhtman T, Slaney C, Stapp E, Szelinger S, Tarwater B, Zandi PP, Kelsoe JR.

Neuropsychopharmacology. 2019 Feb;44(3):620-628. doi: 10.1038/s41386-018-0273-8. Epub 2018 Nov 16.

11.

Patterns of changes in bipolar depressive symptoms revealed by trajectory analysis among 482 patients with bipolar disorder.

Behrendt-Møller I, Madsen T, Sørensen HJ, Sylvia L, Friedman ES, Shelton RC, Bowden CL, Calabrese JR, McElroy SL, Ketter TA, Reilly-Harrington NA, Gao K, Thase M, V Bobo W, Tohen M, McInnis M, Kamali M, Kocsis JH, Deckersbach T, Köhler-Forsberg O, Nierenberg AA.

Bipolar Disord. 2019 Jun;21(4):350-360. doi: 10.1111/bdi.12715. Epub 2018 Dec 1.

PMID:
30383333
12.

Correlation between depression/anxiety symptom severity and quality of life in patients with major depressive disorder or bipolar disorder.

Gao K, Su M, Sweet J, Calabrese JR.

J Affect Disord. 2019 Feb 1;244:9-15. doi: 10.1016/j.jad.2018.09.063. Epub 2018 Sep 17.

PMID:
30292023
13.

The impact of binge eating behavior on lithium- and quetiapine-associated changes in body weight, body mass index, and waist circumference during 6 months of treatment: Findings from the bipolar CHOICE study.

Yaramala SR, McElroy SL, Geske J, Winham S, Gao K, Reilly-Harrington NA, Ketter TA, Deckersbach T, Kinrys G, Kamali M, Sylvia LG, McInnis MG, Friedman ES, Thase ME, Kocsis JH, Tohen M, Calabrese JR, Bowden CL, Shelton RC, Nierenberg AA, Bobo WV.

J Affect Disord. 2018 Sep 12. pii: S0165-0327(18)30069-7. doi: 10.1016/j.jad.2018.09.025. [Epub ahead of print]

PMID:
30241956
14.

The safety and tolerability of aripiprazole once-monthly as maintenance treatment for bipolar I disorder: A double-blind, placebo-controlled, randomized withdrawal study.

Calabrese JR, Sanchez R, Jin N, Amatniek J, Cox K, Johnson B, Perry PP, Hertel P, Such P, McQuade RD, Nyilas M, Carson WH.

J Affect Disord. 2018 Dec 1;241:425-432. doi: 10.1016/j.jad.2018.06.043. Epub 2018 Jul 6.

15.

A Pilot Study of the Effectiveness of Lithium Versus Quetiapine Immediate Release Monotherapy in Patients With Bipolar Spectrum Disorders.

Gao K, Goto T, Yuan C, Brownrigg B, Conroy C, Chan PK, Serrano MB, Ganocy SJ, Fang F, Calabrese JR.

J Clin Psychopharmacol. 2018 Oct;38(5):422-434. doi: 10.1097/JCP.0000000000000927.

PMID:
30102627
16.

Subthreshold PTSD and PTSD in a prospective-longitudinal cohort of military personnel: Potential targets for preventive interventions.

Fink DS, Gradus JL, Keyes KM, Calabrese JR, Liberzon I, Tamburrino MB, Cohen GH, Sampson L, Galea S.

Depress Anxiety. 2018 Nov;35(11):1048-1055. doi: 10.1002/da.22819. Epub 2018 Aug 12.

PMID:
30099820
17.

Aripiprazole once-monthly as maintenance treatment for bipolar I disorder: a 52-week, multicenter, open-label study.

Calabrese JR, Jin N, Johnson B, Such P, Baker RA, Madera J, Hertel P, Ottinger J, Amatniek J, Kawasaki H.

Int J Bipolar Disord. 2018 Jun 10;6(1):14. doi: 10.1186/s40345-018-0122-z.

18.

Corrigendum to "General distress is more important than PTSD's cognitions and mood alterations factor in accounting for PTSD and depression's comorbidity" [J. Affect. Disord. 211 (2017) 118-123].

Byllesby BM, Elhai JD, Tamburrino M, Fine TH, Cohen G, Sampson L, Shirley E, Chan PK, Liberzon I, Galea S, Calabrese JR.

J Affect Disord. 2018 Jul;234:289. doi: 10.1016/j.jad.2018.03.004. Epub 2018 Mar 21. No abstract available.

PMID:
29554618
19.

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.

Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, Sharma V, Goldstein BI, Rej S, Beaulieu S, Alda M, MacQueen G, Milev RV, Ravindran A, O'Donovan C, McIntosh D, Lam RW, Vazquez G, Kapczinski F, McIntyre RS, Kozicky J, Kanba S, Lafer B, Suppes T, Calabrese JR, Vieta E, Malhi G, Post RM, Berk M.

Bipolar Disord. 2018 Mar;20(2):97-170. doi: 10.1111/bdi.12609. Epub 2018 Mar 14.

20.

Bipolar disorders.

Vieta E, Berk M, Schulze TG, Carvalho AF, Suppes T, Calabrese JR, Gao K, Miskowiak KW, Grande I.

Nat Rev Dis Primers. 2018 Mar 8;4:18008. doi: 10.1038/nrdp.2018.8. Review.

PMID:
29516993
21.

Symptoms and functioning with aripiprazole once-monthly injection as maintenance treatment for bipolar I disorder.

Calabrese JR, Sanchez R, Jin N, Amatniek J, Cox K, Johnson B, Perry P, Hertel P, Such P, McQuade RD, Nyilas M, Carson WH.

J Affect Disord. 2018 Feb;227:649-656. doi: 10.1016/j.jad.2017.10.035. Epub 2017 Oct 24.

PMID:
29174738
22.

Decreased activation and subsyndromal manic symptoms predict lower remission rates in bipolar depression.

Caldieraro MA, Walsh S, Deckersbach T, Bobo WV, Gao K, Ketter TA, Shelton RC, Reilly-Harrington NA, Tohen M, Calabrese JR, Thase ME, Kocsis JH, Sylvia LG, Nierenberg AA.

Aust N Z J Psychiatry. 2018 Oct;52(10):994-1002. doi: 10.1177/0004867417741982. Epub 2017 Nov 16.

PMID:
29143534
23.

Sleep disturbance may impact treatment outcome in bipolar disorder: A preliminary investigation in the context of a large comparative effectiveness trial.

Sylvia LG, Chang WC, Kamali M, Tohen M, Kinrys G, Deckersbach T, Calabrese JR, Thase ME, Reilly-Harrington N, Bobo WV, Kocsis JH, McInnis MG, Bowden CL, Ketter TA, Friedman ES, Shelton RC, McElroy SL, Gao K, Rabideau DJ, Nierenberg AA.

J Affect Disord. 2018 Jan 1;225:563-568. doi: 10.1016/j.jad.2017.08.056. Epub 2017 Aug 19.

PMID:
28881294
24.

Corrigendum to bipolar mixed features - Results from the comparative effectiveness for bipolar disorder (Bipolar CHOICE) study [Journal of Affective Disorders 217 (2017) 183-189].

Tohen M, Gold AK, Sylvia LG, Montana RE, McElroy SL, Thase ME, Rabideau DJ, Nierenberg AA, Reilly-Harrington NA, Friedman ES, Shelton RC, Bowden CL, Singh V, Deckersbach T, Ketter TA, Calabrese JR, Bobo WV, McInnis MG.

J Affect Disord. 2018 Jan 1;225:775-777. doi: 10.1016/j.jad.2017.08.032. Epub 2017 Aug 18. No abstract available.

PMID:
28826887
25.

A Double-Blind and Placebo-Controlled Trial of Aripiprazole in Symptomatic Youths at Genetic High Risk for Bipolar Disorder.

Findling RL, Youngstrom EA, Rowles BM, Deyling E, Lingler J, Stansbrey RJ, McVoy M, Lytle S, Calabrese JR, McNamara NK.

J Child Adolesc Psychopharmacol. 2017 Dec;27(10):864-874. doi: 10.1089/cap.2016.0160. Epub 2017 Jul 31.

PMID:
28759262
26.

Trajectories of suicidal ideation over 6 months among 482 outpatients with bipolar disorder.

Köhler-Forsberg O, Madsen T, Behrendt-Møller I, Sylvia L, Bowden CL, Gao K, Bobo WV, Trivedi MH, Calabrese JR, Thase M, Shelton RC, McInnis M, Tohen M, Ketter TA, Friedman ES, Deckersbach T, McElroy SL, Reilly-Harrington NA, Nierenberg AA.

J Affect Disord. 2017 Dec 1;223:146-152. doi: 10.1016/j.jad.2017.07.038. Epub 2017 Jul 20.

PMID:
28755622
27.

Lurasidone in combination with lithium or valproate for the maintenance treatment of bipolar I disorder.

Calabrese JR, Pikalov A, Streicher C, Cucchiaro J, Mao Y, Loebel A.

Eur Neuropsychopharmacol. 2017 Sep;27(9):865-876. doi: 10.1016/j.euroneuro.2017.06.013. Epub 2017 Jul 6.

28.

Efficacy and safety of sublingual ramelteon as an adjunctive therapy in the maintenance treatment of bipolar I disorder in adults: A phase 3, randomized controlled trial.

Mahableshwarkar AR, Calabrese JR, Macek TA, Budur K, Adefuye A, Dong X, Hanson E, Sachs GS.

J Affect Disord. 2017 Oct 15;221:275-282. doi: 10.1016/j.jad.2017.06.044. Epub 2017 Jun 20.

29.

Depression severity and quality of life of qualified and unqualified patients with a mood disorder for a research study targeting anhedonia in a clinical sample.

Gao K, Sweet J, Su M, Calabrese JR.

Asian J Psychiatr. 2017 Jun;27:40-47. doi: 10.1016/j.ajp.2017.02.013. Epub 2017 Feb 14.

PMID:
28558894
30.

A placebo controlled study of quetiapine-XR in bipolar depression accompanied by generalized anxiety with and without a recent history of alcohol and cannabis use.

Gao K, Ganocy SJ, Conroy C, Brownrigg B, Serrano MB, Calabrese JR.

Psychopharmacology (Berl). 2017 Aug;234(15):2233-2244. doi: 10.1007/s00213-017-4642-5. Epub 2017 May 24.

PMID:
28536866
31.

Deployment and Alcohol Use in a Military Cohort: Use of Combined Methods to Account for Exposure-Related Covariates and Heterogeneous Response to Exposure.

Fink DS, Keyes KM, Calabrese JR, Liberzon I, Tamburrino MB, Cohen GH, Sampson L, Galea S.

Am J Epidemiol. 2017 Aug 15;186(4):411-419. doi: 10.1093/aje/kww230.

32.

Bipolar mixed features - Results from the comparative effectiveness for bipolar disorder (Bipolar CHOICE) study.

Tohen M, Gold AK, Sylvia LG, Montana RE, McElroy SL, Thase ME, Rabideau DJ, Nierenberg AA, Reilly-Harrington NA, Friedman ES, Shelton RC, Bowden CL, Singh V, Deckersbach T, Ketter TA, Calabrese JR, Bobo WV, McInnis MG.

J Affect Disord. 2017 Aug 1;217:183-189. doi: 10.1016/j.jad.2017.03.070. Epub 2017 Apr 5. Erratum in: J Affect Disord. 2018 Jan 1;225:775-777.

PMID:
28411507
33.

Clinical correlates of acute bipolar depressive episode with psychosis.

Caldieraro MA, Sylvia LG, Dufour S, Walsh S, Janos J, Rabideau DJ, Kamali M, McInnis MG, Bobo WV, Friedman ES, Gao K, Tohen M, Reilly-Harrington NA, Ketter TA, Calabrese JR, McElroy SL, Thase ME, Shelton RC, Bowden CL, Kocsis JH, Deckersbach T, Nierenberg AA.

J Affect Disord. 2017 Aug 1;217:29-33. doi: 10.1016/j.jad.2017.03.059. Epub 2017 Mar 30.

PMID:
28365478
34.

Efficacy and Safety of Aripiprazole Once-Monthly in the Maintenance Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled, 52-Week Randomized Withdrawal Study.

Calabrese JR, Sanchez R, Jin N, Amatniek J, Cox K, Johnson B, Perry P, Hertel P, Such P, Salzman PM, McQuade RD, Nyilas M, Carson WH.

J Clin Psychiatry. 2017 Mar;78(3):324-331. doi: 10.4088/JCP.16m11201.

35.

Coincident alcohol dependence and depression increases risk of suicidal ideation among Army National Guard soldiers.

Cohen GH, Fink DS, Sampson L, Tamburrino M, Liberzon I, Calabrese JR, Galea S.

Ann Epidemiol. 2017 Mar;27(3):157-163.e1. doi: 10.1016/j.annepidem.2016.12.004. Epub 2016 Dec 14.

36.

Nonsteroidal anti-inflammatory drugs (NSAIDs) and paracetamol do not affect 6-month mood-stabilizing treatment outcome among 482 patients with bipolar disorder.

Köhler-Forsberg O, Sylvia L, Thase M, Calabrese JR, Deckersbach T, Tohen M, Bowden CL, McInnis M, Kocsis JH, Friedman ES, Ketter TA, McElroy S, Shelton RC, Nierenberg AA.

Depress Anxiety. 2017 Mar;34(3):281-290. doi: 10.1002/da.22601. Epub 2017 Jan 30.

37.

General distress is more important than PTSD's cognition and mood alterations factor in accounting for PTSD and depression's comorbidity.

Byllesby BM, Elhai JD, Tamburrino M, Fine TH, Cohen G, Sampson L, Shirley E, Chan PK, Liberzon I, Galea S, Calabrese JR.

J Affect Disord. 2017 Mar 15;211:118-123. doi: 10.1016/j.jad.2017.01.014. Epub 2017 Jan 15. Erratum in: J Affect Disord. 2018 Mar 16;234:289.

PMID:
28110158
38.

Diagnosing Mania in the Age of DSM-5.

Calabrese JR, Gao K, Sachs G.

Am J Psychiatry. 2017 Jan 1;174(1):8-10. doi: 10.1176/appi.ajp.2016.16091084. No abstract available.

PMID:
28040998
39.

Is there a 'weight neutral' second-generation antipsychotic for bipolar disorder?

Fang F, Wang Z, Wu R, Calabrese JR, Gao K.

Expert Rev Neurother. 2017 Apr;17(4):407-418. doi: 10.1080/14737175.2016.1276284. Epub 2017 Jan 2. Review.

PMID:
28005435
40.

Subjective Versus Objective Weight Gain During Acute Treatment With Second-Generation Antipsychotics in Schizophrenia and Bipolar Disorder.

Gao K, Fang F, Wang Z, Calabrese JR.

J Clin Psychopharmacol. 2016 Dec;36(6):637-642. Review.

PMID:
27753728
41.

A Randomized, Placebo-Controlled Pilot Study of Quetiapine-XR Monotherapy or Adjunctive Therapy to Antidepressant in Acute Major Depressive Disorder with Current Generalized Anxiety Disorder.

Li R, Wu R, Chen J, Kemp DE, Ren M, Conroy C, Chan P, Serrano MB, Ganocy SJ, Calabrese JR, Gao K.

Psychopharmacol Bull. 2016 Mar 1;46(1):8-23.

42.

Incidence and Risk for Mood and Anxiety Disorders in a Representative Sample of Ohio Army National Guard Members, 2008-2012.

Fink DS, Chen Q, Liu Y, Tamburrino MB, Liberzon I, Shirley E, Fine T, Cohen GH, Galea S, Calabrese JR.

Public Health Rep. 2016 Jul-Aug;131(4):614-22.

43.

Tracking medication changes to assess outcomes in comparative effectiveness research: A bipolar CHOICE study.

Reilly-Harrington NA, Sylvia LG, Rabideau DJ, Gold AK, Deckersbach T, Bowden CL, Bobo WV, Singh V, Calabrese JR, Shelton RC, Friedman ES, Thase ME, Kamali M, Tohen M, McInnis MG, McElroy SL, Ketter TA, Kocsis JH, Kinrys G, Nierenberg AA.

J Affect Disord. 2016 Nov 15;205:159-164. doi: 10.1016/j.jad.2016.07.007. Epub 2016 Jul 5.

PMID:
27449548
44.

Couples Therapy for Intimate Partner Violence: A Systematic Review and Meta-Analysis.

Karakurt G, Whiting K, van Esch C, Bolen SD, Calabrese JR.

J Marital Fam Ther. 2016 Oct;42(4):567-583. doi: 10.1111/jmft.12178. Epub 2016 Jul 5. Review.

45.

Antipsychotic Drug-Induced Somnolence: Incidence, Mechanisms, and Management.

Fang F, Sun H, Wang Z, Ren M, Calabrese JR, Gao K.

CNS Drugs. 2016 Sep;30(9):845-67. doi: 10.1007/s40263-016-0352-5. Review.

PMID:
27372312
46.

Retrospective age-of-onset and projected lifetime prevalence of psychiatric disorders among U.S. Army National Guard soldiers.

Fink DS, Calabrese JR, Liberzon I, Tamburrino MB, Chan P, Cohen GH, Sampson L, Reed PL, Shirley E, Goto T, D'Arcangelo N, Fine T, Galea S.

J Affect Disord. 2016 Sep 15;202:171-7. doi: 10.1016/j.jad.2016.05.025. Epub 2016 May 18.

47.

The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample.

Oedegaard KJ, Alda M, Anand A, Andreassen OA, Balaraman Y, Berrettini WH, Bhattacharjee A, Brennand KJ, Burdick KE, Calabrese JR, Calkin CV, Claasen A, Coryell WH, Craig D, DeModena A, Frye M, Gage FH, Gao K, Garnham J, Gershon E, Jakobsen P, Leckband SG, McCarthy MJ, McInnis MG, Maihofer AX, Mertens J, Morken G, Nievergelt CM, Nurnberger J, Pham S, Schoeyen H, Shekhtman T, Shilling PD, Szelinger S, Tarwater B, Yao J, Zandi PP, Kelsoe JR.

BMC Psychiatry. 2016 May 5;16:129. doi: 10.1186/s12888-016-0732-x.

48.

White blood cell count correlates with mood symptom severity and specific mood symptoms in bipolar disorder.

Köhler O, Sylvia LG, Bowden CL, Calabrese JR, Thase M, Shelton RC, McInnis M, Tohen M, Kocsis JH, Ketter TA, Friedman ES, Deckersbach T, Ostacher MJ, Iosifescu DV, McElroy S, Nierenberg AA.

Aust N Z J Psychiatry. 2017 Apr;51(4):355-365. doi: 10.1177/0004867416644508. Epub 2016 Jul 11.

PMID:
27126391
49.

Association of Spirituality With Mental Health Conditions in Ohio National Guard Soldiers.

Ganocy SJ, Goto T, Chan PK, Cohen GH, Sampson L, Galea S, Liberzon I, Fine T, Shirley E, Sizemore J, Calabrese JR, Tamburrino MB.

J Nerv Ment Dis. 2016 Jul;204(7):524-9. doi: 10.1097/NMD.0000000000000519.

PMID:
27065107
50.

A randomized, placebo-controlled proof-of-concept trial of adjunctive topiramate for alcohol use disorders in bipolar disorder.

Sylvia LG, Gold AK, Stange JP, Peckham AD, Deckersbach T, Calabrese JR, Weiss RD, Perlis RH, Nierenberg AA, Ostacher MJ.

Am J Addict. 2016 Mar;25(2):94-8. doi: 10.1111/ajad.12346. Epub 2016 Feb 19.

Supplemental Content

Loading ...
Support Center